title: The case for Zostavax vaccination in systemic lupus erythematosus.
authors.affiliation: Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. abbycogman@gmail.com
authors.forename: Abigail R
authors.initials: AR
authors.lastname: Cogman
authors.forename: Eliza F
authors.initials: EF
authors.lastname: Chakravarty
mesh_terms: D000075202:Contraindications; D006562:Herpes Zoster / Q000150:complications*; D053061:Herpes Zoster Vaccine / Q000009:adverse effects; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D017410:Practice Guidelines as Topic; D014611:Vaccination / Q000009:adverse effects*
chemical_list: D053061:Herpes Zoster Vaccine
keywords: Autoimmune diseases; Herpes zoster; Infection; Shingles; Systemic lupus erythematosus; Vaccine; Varicella zoster virus